Literature DB >> 14642499

Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons.

Anne B Rocher1, Françoise Chapon, Xavier Blaizot, Jean-Claude Baron, Chantal Chavoix.   

Abstract

It is classically recognized that regional cerebral glucose consumption (CMRglc), as measured by positron emission tomography (PET) and [18F]-2-fluorodeoxyglucose (FDG), is a precise index of the integrated local neuronal activity. However, despite extensive use of the FDG-PET method, the significance of the measured CMRglc has been little addressed so far. In the present study, we aimed for the first time to test whether resting-state CMRglc is directly related to synaptic density. To this end, we investigated in the baboon the relationships between CMR(glc) and the levels of synaptophysin (SY), a presynaptic protein classically used to assess synaptic density. CMR(glc), measured in vivo by FDG-PET at the resting-state, and SY levels, assessed postmortem by the Western blot technique, were quantified in seven brain areas of five baboons. By applying these two techniques to the same animals, we found significant positive correlations between CMR(glc) and SY levels, across all regions and all animals, as well as within individual baboons. These findings strongly support the hypothesis that resting-state CMR(glc) reflects integrated synaptic activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642499     DOI: 10.1016/j.neuroimage.2003.07.002

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  74 in total

Review 1.  The concept of FDG-PET endophenotype in Alzheimer's disease.

Authors:  Emmanuel H During; R S Osorio; F M Elahi; L Mosconi; M J de Leon
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

2.  Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.

Authors:  Lisa Mosconi; Juha O Rinne; Wai H Tsui; John Murray; Yi Li; Lidia Glodzik; Pauline McHugh; Schantel Williams; Megan Cummings; Elizabeth Pirraglia; Stanley J Goldsmith; Shankar Vallabhajosula; Noora Scheinin; Tapio Viljanen; Kjell Någren; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2012-04-11       Impact factor: 4.673

3.  Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease.

Authors:  S Duke Han; Jonathan Gruhl; Laurel Beckett; Hiroko H Dodge; Nikki H Stricker; Sarah Farias; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

4.  Direct voxel-based comparisons between grey matter shrinkage and glucose hypometabolism in chronic alcoholism.

Authors:  Ludivine Ritz; Shailendra Segobin; Coralie Lannuzel; Céline Boudehent; François Vabret; Francis Eustache; Hélène Beaunieux; Anne L Pitel
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

Review 5.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

Review 6.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

Review 7.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

9.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

10.  Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?

Authors:  Rik Ossenkoppele; Cindee Madison; Hwamee Oh; Miranka Wirth; Bart N M van Berckel; William J Jagust
Journal:  Cereb Cortex       Date:  2013-03-28       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.